Two-phase IVM for poor ovarian response in women under 35
This trial tests a two-phase in-vitro maturation (IVM) method for women under 35 who had poor response to a previous IVF cycle (fewer than 4 eggs retrieved). The goal is to see if this approach helps get more usable eggs and embryos. You would need to freeze all embryos for later transfer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 34 years old.
- You have had at least one IVF cycle that resulted in fewer than 4 eggs being retrieved.
- Your AMH level is 1.2 ng/mL or higher, or you have at least 5 antral follicles on ultrasound.
- You agree to try the two-phase IVM treatment.
- You agree to freeze all embryos and have a frozen embryo transfer later.
- You agree to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two fertility treatments for women with PCOS: in vitro maturation (IVM) with fresh embryo transfer versus standard IVF with frozen embryo transfer. It aims to find which approach leads to better outcomes.
This study tests a fertility treatment called CAPA-IVM, which matures eggs outside the body without strong fertility drugs. It may be an option for women with regular periods who need IVF for the first time.
This study tests a new lab method (called OSC co-culture) to grow immature eggs in the lab so they can mature and be fertilized for research. It aims to learn how to rescue eggs that didn't fully develop, which could help improve future fertility treatments.
This study tests a way to mature eggs outside the body for women with PCOS or high ovarian reserve. It might help avoid side effects from fertility medications.
This study tests a new way of growing eggs in the lab called in vitro maturation (IVM) for women undergoing fertility treatment. It may help women who have concerns about hormone injections, as IVM uses less medication.
This trial tests two different ways to trigger the final maturation of eggs before retrieval in women who are considered poor responders to IVF treatment. It aims to see if a double trigger is more effective than the standard HCG trigger for improving egg and embryo outcomes.
Hear when a new Healthy Adult Females trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.